arrow
Y

Yuxin Liu

Dana-Farber Cancer Institute and Harvard Medical School
H指数:15
被引数:1,204

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myeloma

伊沙妥昔单抗:一种针对多发性骨髓瘤中未满足需求及耐药机制的抗CD38疗法

2026-05-040
PRE
A review of the clinical efficacy of monoclonal antibody (mAb)-based therapies for relapsed/refractory multiple myeloma (RRMM)

单克隆抗体(mAb)为基础的疗法治疗复发/难治性多发性骨髓瘤(RRMM)的临床疗效综述

2026-04-050
PRE
Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant

记忆T细胞对造血干细胞移植患者SARS-CoV-2疫苗反应的影响

2025-04-280
OA
Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection
2023-06-131
OA